AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 501487 — intervention group
Group type: EXPERIMENTAL
Intervention: Ten-session weight reduction program including behavior modification, nutrition education, and exercise management
Number of subjects: 119
Study 501487 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 119
Study 7050331 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 - fluids managed to allow 1 to 2% loss of BW per day to a maximum loss of 8 to 10%
Number of subjects: 88
Study 7050331 — intervention group
Group type: COMPARATOR
Intervention: Group 2 - fluids managed to allow 3 to 5% loss of BW per day to a maximum loss of 13 to 15%
Number of subjects: 88
Study 7050331 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 88
Study 29786959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg with Sitagliptin 100 mg
Number of subjects: 66
Study 29786959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg with Metformin 1000 mg
Number of subjects: 66
Study 29786959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg with Glimepiride 1 mg
Number of subjects: 66
Study 29786959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg with Simvastatin 40 mg
Number of subjects: 66
Study 29786959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin
Number of subjects: 66
Study 26160548 — intervention group
Group type: EXPERIMENTAL
Intervention: Jasmine rice (JR)
Number of subjects: 75
Study 26160548 — intervention group
Group type: COMPARATOR
Intervention: Basmati rice (BR)
Number of subjects: 75
Study 26160548 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of chews per mouthful (JR)
Number of subjects: 75
Study 26160548 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of chews per mouthful (BR)
Number of subjects: 75
Study 26160548 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing time per mouthful (JR)
Number of subjects: 75
Study 26160548 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing time per mouthful (BR)
Number of subjects: 75
Study 24559217 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 235
Study 21703829 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice, twice a day for 6 weeks (including 2 weeks post-treatment)
Number of subjects: 0
Study 21703829 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage, twice a day for 6 weeks (including 2 weeks post-treatment)
Number of subjects: 0
Study 20110568 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrying more than 22 risk-alleles
Number of subjects: 3925
Study 20110568 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 SNPs combined with conventional nongenetic risk factors
Number of subjects: 3925
Study 18037444 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition to Community program, involving interviews by an advanced practice psychiatric nurse, communication via prepaid cellular phones, and follow-up on medication compliance and outpatient appointments.
Number of subjects: 13
Study 16096584 — intervention group
Group type: EXPERIMENTAL
Intervention: DIBrH SPECT images
Number of subjects: 28
Study 12381235 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined antiretroviral therapy in elderly patients
Number of subjects: 0
Study 12381235 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly active antiretroviral therapy (HAART)
Number of subjects: 0
Study 12381235 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral treatment and therapy guidelines
Number of subjects: 0
Study 12381235 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral drug dosage adjustment
Number of subjects: 0
Study 10525248 — intervention group
Group type: EXPERIMENTAL
Intervention: VENTAK AV device
Number of subjects: 69
Study 10525248 — intervention group
Group type: COMPARATOR
Intervention: VENTAK MINI device (control)
Number of subjects: 69
Study 7723928 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine
Number of subjects: 7
Study 7723928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 2025037 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway pressure trigger
Number of subjects: 10
Study 2025037 — intervention group
Group type: COMPARATOR
Intervention: Graseby MR10 respiration monitor
Number of subjects: 10
Study 6449902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous mezlocillin, 260 mg/kg/day in six divided doses
Number of subjects: 23
Study 6449902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous mezlocillin, 450 mg/kg/day in six divided doses
Number of subjects: 23
Study 6449902 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined results from both dosage regimens
Number of subjects: 23
Study 6449902 — intervention group
Group type: EXPERIMENTAL
Intervention: Mezlocillin
Number of subjects: 23
Study 29600400 — intervention group
Group type: EXPERIMENTAL
Intervention: fesoterodine 8 mg
Number of subjects: 630
Study 29600400 — intervention group
Group type: COMPARATOR
Intervention: fesoterodine 4 mg
Number of subjects: 630
Study 30296323 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-to-surgery <24 hours
Number of subjects: 6036
Study 30296323 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-to-surgery 24-48 hours
Number of subjects: 6036
Study 30296323 — intervention group
Group type: COMPARATOR
Intervention: Time-to-surgery >48 hours
Number of subjects: 6036
Study 30296323 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-to-surgery
Number of subjects: 6036
Study 27693901 — intervention group
Group type: EXPERIMENTAL
Intervention: Stop-and-go methadone titration method
Number of subjects: 146
Study 27693901 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive methadone titration method
Number of subjects: 146
Study 27693901 — intervention group
Group type: COMPARATOR
Intervention: Both methods
Number of subjects: 146
Study 24225312 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pack
Number of subjects: 24
Study 24225312 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot pack
Number of subjects: 24
Study 24225312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 24
Study 24225312 — intervention group
Group type: COMPARATOR
Intervention: Control (no thermal agent)
Number of subjects: 24
Study 22325080 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoamine depletion (acute combined tryptophan, tyrosine, and phenylalanine depletion)
Number of subjects: 12
Study 22325080 — intervention group
Group type: COMPARATOR
Intervention: Balanced condition (consumption of a beverage containing tryptophan, tyrosine, and phenylalanine)
Number of subjects: 12
Study 22325080 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoamine depletion
Number of subjects: 12
Study 22325080 — intervention group
Group type: COMPARATOR
Intervention: Balanced condition
Number of subjects: 12
Study 19672115 — intervention group
Group type: EXPERIMENTAL
Intervention: Dead Sea mineral-enriched body lotion (DS)
Number of subjects: 78
Study 19672115 — intervention group
Group type: COMPARATOR
Intervention: Placebo lotion with no Dead Sea minerals (P1)
Number of subjects: 78
Study 19672115 — intervention group
Group type: COMPARATOR
Intervention: Placebo lotion with no active ingredients (P2)
Number of subjects: 78
Study 19672115 — intervention group
Group type: COMPARATOR
Intervention: Combined placebo groups (P1 and P2)
Number of subjects: 78
Study 17218057 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal physiotherapy program (MPT)
Number of subjects: 71
Study 17218057 — intervention group
Group type: COMPARATOR
Intervention: Self-management program (SMP)
Number of subjects: 71
Study 16377592 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 12109234 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual hyperinflation
Number of subjects: 20
Study 12109234 — intervention group
Group type: COMPARATOR
Intervention: Ventilator hyperinflation
Number of subjects: 20
Study 9855261 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Number of subjects: 45
Study 9855261 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated with H. pylori eradication)
Number of subjects: 45
Study 7530168 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP chemotherapy
Number of subjects: 392
Study 7530168 — intervention group
Group type: COMPARATOR
Intervention: m‐BACOD chemotherapy
Number of subjects: 392
Study 7530168 — intervention group
Group type: EXPERIMENTAL
Intervention: LDH level normal or below
Number of subjects: 392
Study 7530168 — intervention group
Group type: EXPERIMENTAL
Intervention: LDH level 1-3 x normal
Number of subjects: 392
Study 7530168 — intervention group
Group type: EXPERIMENTAL
Intervention: LDH level > 3 x normal
Number of subjects: 392
Study 7530168 — intervention group
Group type: EXPERIMENTAL
Intervention: International Index low risk group
Number of subjects: 392
Study 7530168 — intervention group
Group type: EXPERIMENTAL
Intervention: International Index low/intermediate risk group
Number of subjects: 392
Study 7530168 — intervention group
Group type: EXPERIMENTAL
Intervention: International Index high/intermediate risk group
Number of subjects: 392
Study 7530168 — intervention group
Group type: EXPERIMENTAL
Intervention: International Index high risk group
Number of subjects: 392
Study 2225700 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg mefloquine hydrochloride
Number of subjects: 37
Study 2225700 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg mefloquine hydrochloride
Number of subjects: 37
Study 2225700 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg and 1500 mg mefloquine hydrochloride
Number of subjects: 37
Study 634895 — intervention group
Group type: EXPERIMENTAL
Intervention: TNS (transcutaneous nerve stimulation)
Number of subjects: 30
Study 634895 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine (50 mg intravenously)
Number of subjects: 30
Study 634895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 634895 — intervention group
Group type: COMPARATOR
Intervention: Unspecific TNS
Number of subjects: 30
Study 634895 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 31670238 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of all four image contrasts (FLAIR, T1, T2, proton density)
Number of subjects: 1000
Study 31670238 — intervention group
Group type: EXPERIMENTAL
Intervention: FLAIR alone
Number of subjects: 1000
Study 31670238 — intervention group
Group type: EXPERIMENTAL
Intervention: All image combinations
Number of subjects: 1000
Study 31670238 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesion size
Number of subjects: 1000
Study 31719124 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus sequencing
Number of subjects: 0
Study 31719124 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 28111430 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT with erlotinib followed by erlotinib (arm A)
Number of subjects: 59
Study 28111430 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT with irinotecan-cisplatin (IP) only (arm B)
Number of subjects: 59
Study 28111430 — intervention group
Group type: EXPERIMENTAL
Intervention: IP before CCRT (arm C)
Number of subjects: 59
Study 28111430 — intervention group
Group type: EXPERIMENTAL
Intervention: IP after CCRT (arm D)
Number of subjects: 59
Study 28111430 — intervention group
Group type: EXPERIMENTAL
Intervention: EGFR-mutant patients
Number of subjects: 59
Study 28111430 — intervention group
Group type: EXPERIMENTAL
Intervention: EGFR-wild patients
Number of subjects: 59
Study 25204231 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on exercise (group 1)
Number of subjects: 94
Study 25204231 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive exercise (group 2)
Number of subjects: 94
Study 25204231 — intervention group
Group type: COMPARATOR
Intervention: No warm-up (control, group 3)
Number of subjects: 94
Study 22935738 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowered BMI category or remained in healthy or overweight groups
Number of subjects: 3998
Study 22935738 — intervention group
Group type: COMPARATOR
Intervention: Stayed obese
Number of subjects: 3998
Study 22935738 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased a BMI category
Number of subjects: 3998
Study 22935738 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased a BMI category
Number of subjects: 3998
Study 21270194 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting Plasma Glucose (FPG) ≥ 126 mg/dL
Number of subjects: 0
Study 21270194 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA(1c) ≥ 6.5%
Number of subjects: 0
Study 21270194 — intervention group
Group type: EXPERIMENTAL
Intervention: Both FPG and HbA(1c)
Number of subjects: 0
Study 18377903 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 74
Study 16197921 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium infusion (0.1 mmol/kg)
Number of subjects: 31
Study 16197921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 14510997 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC in Transfersome (2.5 micro g cm‐2)
Number of subjects: 0
Study 14510997 — intervention group
Group type: COMPARATOR
Intervention: TAC cream (25 micro g cm‐2)
Number of subjects: 0
Study 14510997 — intervention group
Group type: COMPARATOR
Intervention: TAC ointment (25 micro g cm‐2)
Number of subjects: 0
Study 14510997 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC in Transfersome
Number of subjects: 0
Study 14510997 — intervention group
Group type: COMPARATOR
Intervention: TAC cream
Number of subjects: 0
Study 10761963 — intervention group
Group type: COMPARATOR
Intervention: Annual multidimensional assessments and quarterly follow-up in-home visits by public health nurses (nurses A, B, and C) for low-risk participants.
Number of subjects: 791
Study 10761963 — intervention group
Group type: COMPARATOR
Intervention: Annual multidimensional assessments and quarterly follow-up in-home visits by public health nurses (nurses A and B) for low-risk participants.
Number of subjects: 791
Study 10761963 — intervention group
Group type: COMPARATOR
Intervention: Annual multidimensional assessments and quarterly follow-up in-home visits by public health nurse C for low-risk participants.
Number of subjects: 791
Study 10761963 — intervention group
Group type: COMPARATOR
Intervention: Annual multidimensional assessments and quarterly follow-up in-home visits for high-risk participants.
Number of subjects: 791
Study 8798244 — intervention group
Group type: EXPERIMENTAL
Intervention: Special premature formula (PF)
Number of subjects: 30
Study 8798244 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified human milk (HM)
Number of subjects: 30
Study 8798244 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (PN)
Number of subjects: 30
Study 8798244 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 30
Study 1450797 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 50 mg and Misoprostol 200 micrograms
Number of subjects: 361
Study 1450797 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 50 mg and Placebo
Number of subjects: 361
Study 6372261 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced Diffusion Ventilation (FDV)
Number of subjects: 23
Study 6372261 — intervention group
Group type: EXPERIMENTAL
Intervention: High Frequency Pulsation (HFP)
Number of subjects: 23
Study 6372261 — intervention group
Group type: COMPARATOR
Intervention: Intermittent Positive Pressure Ventilation (IPPV)
Number of subjects: 23
Study 31383583 — intervention group
Group type: EXPERIMENTAL
Intervention: More intensive reminders
Number of subjects: 20757
Study 31383583 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter inter-donation intervals
Number of subjects: 20757
Study 31383583 — intervention group
Group type: COMPARATOR
Intervention: Routine reminders
Number of subjects: 20757
Study 29223708 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS)
Number of subjects: 41
Study 29223708 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (tDCS)
Number of subjects: 41
Study 29223708 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial magnetic stimulation/sham tDCS
Number of subjects: 41
Study 26541138 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 40 mg
Number of subjects: 13
Study 26541138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 25691677 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen-Deprivation Therapy plus Radiotherapy (ADT+RT)
Number of subjects: 1205
Study 25691677 — intervention group
Group type: COMPARATOR
Intervention: Androgen-Deprivation Therapy alone (ADT)
Number of subjects: 1205
Study 22905934 — intervention group
Group type: EXPERIMENTAL
Intervention: True narratives (trip to a theme park)
Number of subjects: 0
Study 22905934 — intervention group
Group type: EXPERIMENTAL
Intervention: False narratives (hot air balloon ride)
Number of subjects: 0
Study 22905934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonbelieved memories
Number of subjects: 0
Study 22905934 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with nonbelieved memories
Number of subjects: 0
Study 22905934 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with false memories who retracted their claim
Number of subjects: 0
Study 21199265 — intervention group
Group type: EXPERIMENTAL
Intervention: colesevelam 3.75 g/day
Number of subjects: 40
Study 21199265 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 19112781 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 619
Study 19112781 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 619
Study 17132352 — intervention group
Group type: EXPERIMENTAL
Intervention: General practice-based complex intervention to support the implementation of clinical guidelines for hepatitis C management
Number of subjects: 26
Study 17132352 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control group)
Number of subjects: 26
Study 17132352 — intervention group
Group type: EXPERIMENTAL
Intervention: General practice-based complex intervention
Number of subjects: 26
Study 12973958 — intervention group
Group type: EXPERIMENTAL
Intervention: adrenaline 0.5 microgram/kg
Number of subjects: 75
Study 12973958 — intervention group
Group type: EXPERIMENTAL
Intervention: adrenaline 0.5 microgram/kg and clonidine 0.3 microgram/kg
Number of subjects: 75
Study 12973958 — intervention group
Group type: COMPARATOR
Intervention: clonidine 0.3 microgram/kg
Number of subjects: 75
Study 10798541 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood stem cell transplantation (PBSCT)
Number of subjects: 28
Study 10798541 — intervention group
Group type: EXPERIMENTAL
Intervention: PBSCT
Number of subjects: 28
Study 9403260 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily application of povidone-iodine
Number of subjects: 72
Study 9403260 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily application of povidone-iodine
Number of subjects: 72
Study 9403260 — intervention group
Group type: EXPERIMENTAL
Intervention: Once or twice daily application of povidone-iodine
Number of subjects: 72
Study 7917797 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil 250 mg twice daily
Number of subjects: 296
Study 7917797 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin 250 mg three times daily
Number of subjects: 296
Study 2844087 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 0
Study 2844087 — intervention group
Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 0
Study 30515164 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLF)
Number of subjects: 15
Study 30515164 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLF) + GOS
Number of subjects: 15
Study 30515164 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLF) + GOS + vitamin D
Number of subjects: 15
Study 30515164 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 15
Study 28349708 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 15
Study 28349708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 25738794 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgery (hematoma evacuation within 12h of randomization)
Number of subjects: 170
Study 25738794 — intervention group
Group type: COMPARATOR
Intervention: Initial conservative treatment (subsequent evacuation allowed if deemed necessary)
Number of subjects: 170
Study 24765719 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐Concept Enhancement Program (SCEP) for 8 weeks
Number of subjects: 60
Study 24765719 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 60
Study 22659382 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 0
Study 20204945 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced counselling (EC) intervention
Number of subjects: 134
Study 20204945 — intervention group
Group type: COMPARATOR
Intervention: Control condition (standard individualised counselling + general health information session)
Number of subjects: 134
Study 18541328 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone 4mg/day
Number of subjects: 40
Study 18541328 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 15818104 — intervention group
Group type: COMPARATOR
Intervention: Increased PLA2 levels in BAL fluid, BAL cells, and plasma in ARDS patients
Number of subjects: 31
Study 15818104 — intervention group
Group type: COMPARATOR
Intervention: Type IIA secretory and cytosolic PLA2 in BAL fluid
Number of subjects: 31
Study 15818104 — intervention group
Group type: COMPARATOR
Intervention: Total PLA2 activity
Number of subjects: 31
Study 15818104 — intervention group
Group type: COMPARATOR
Intervention: Higher PLA2 activity in direct ARDS
Number of subjects: 31
Study 15818104 — intervention group
Group type: COMPARATOR
Intervention: Higher platelet-activating-factor acetylhydrolase activity in BAL fluid and plasma
Number of subjects: 31
Study 12271281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy followed by topical imiquimod and salicylic acid
Number of subjects: 3
Study 10357032 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 340